7.12.2023
•
News
M&A
TMT
Advice to Seyfor Group on Expanding its Portfolio
Seyfor Group, one of Europe's largest ICT solutions providers and KSB’s long-standing clients, has once again expanded its portfolio. This time it has acquired a 100% stake in the company KS – program.
With this acquisition, Seyfor increases its market share in the area of payroll and HR systems for medium and large enterprises. KS - program's clients include Škoda Praha, Hyundai Motor Czech, as well as the Senate and the Moravian-Silesian regional government.
KSB's team of Ján Béreš, Josef Novotný and Drahomír Tomašuk, supplemented by other colleagues who handled specific issues, was in charge of legal due diligence and drafting and negotiating the transaction documentation.
Details are outlined in the client's press release.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
